Vizgen · 1 month ago
Marketing Manager- EMEA
Vizgen is a rapidly growing company developing spatially resolved genomic profiling tools, and they are seeking a Field Marketing Manager for the EMEA region. This role involves executing diverse marketing strategies, coordinating with sales and marketing teams, and managing customer-facing events to optimize market strategy in EMEA.
BiotechnologyHealth CareLife ScienceMedical
Responsibilities
Coordinate with the Regional Vice President of Sales for strategic approach to marketing programs that can be facilitated and executed at the regional and account level in coordination with Inside Sales
Coordinate with Product, Digital Marketing, and Sales teams to develop integrated marketing campaigns and sales tools for lead management for EMEA
Organize field customer facing events (seminars, workshops, vendors shows, local conferences etc.)
Identify opportunities for customer case studies, webinars or other co-marketing engagements and coordinate with the global marketing team
Closely engage with Vizgen Product Management team funneling VOC and product feedback through established processes
Qualification
Required
B.S. or advanced degree in business or science
Multiple years of experience within Life Science or Biotechnology commercial company in a marketing role
Collaborates easily with other team members to drive joint success
Must be able to accomplish results in a cross-functional team environment, exhibiting formal and informal leadership skills
Highly motivated and results orientated
Understanding of the strategic competitive landscape
Ability to work and adapt to rapidly changing environments
Ability to prioritize & manage multiple projects at the same time
Excellent verbal communication, presentation, and writing skills
English required, but other European language like French, Spanish, German etc. is a plus
Ability to travel up to 50%
Company
Vizgen
Vizgen provides spatial multi-omics platforms enabling researchers to reveal cellular insights through spatial transcriptomics proteomics.
Funding
Current Stage
Late StageTotal Funding
$187.7M2026-01-08Series E· $48M
2025-10-07Debt Financing· $3.5M
2024-10-09Series D
Recent News
2026-01-11
Business Wire
2026-01-09
2026-01-09
Company data provided by crunchbase